Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 11;17(9):1236.
doi: 10.3390/v17091236.

Viral Burden of Respiratory Syncytial Virus and Viral Coinfections as Factors Regulating Paediatric Disease Severity

Affiliations

Viral Burden of Respiratory Syncytial Virus and Viral Coinfections as Factors Regulating Paediatric Disease Severity

Velia Chiara Di Maio et al. Viruses. .

Abstract

Background: Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infections (ARIs) in children. However, the clinical impact of RSV co-infection with other respiratory viruses remains unclear. This study investigates the frequency and clinical outcomes of RSV infections in a large paediatric cohort.

Methods: Paediatric patients with RSV-positive respiratory samples admitted to Bambino Gesù Children's Hospital between January 2022 and April 2024 were analysed.

Results: Within 17,259 respiratory samples from 9877 paediatric patients, 952 (9.6%) were RSV-positive. Among these, 637 patients with ARI were included. RSV affected the lower respiratory tract in 549 cases (86.2%) and the upper tract in 88 (13.8%) cases. RSV mono-infection was found in 286 (44.9%) patients, while 351 (55.1%) patients had co-infections. Mono-infections showed lower cycle-threshold (CT) than co-infections in both upper and lower tract (p-value:0.002 and 0.037, respectively). Pneumonia was associated with RSV co-infection (N = 48, 15.4%), whereas bronchiolitis was mostly seen in mono-infection (N = 196, 78.1%, p-value:0.002). Regression analysis showed an association between pneumonia and co-infection (AOR: 1.97 [1.06-3.64], p-value = 0.031), higher CT (AOR [95% CI]: 1.07 [1.02-1.11], p-value = 0.006) and older age (AOR [95% CI]: 1.48 [1.31-1.68], p-value < 0.001), whereas bronchiolitis was associated with mono-infection, younger age and lower CT.

Conclusions: This study highlights the role of RSV in paediatric disease and emphasises the importance of early diagnosis, personalised treatment and preventive strategies to improve outcomes and reduce the burden of disease.

Keywords: co-infection; disease burden; disease severity; paediatric patients; respiratory syncytial virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Distribution of viral detections in positive respiratory samples with a SARS-CoV-2 test available in the overall population (A) and according to upper and lower respiratory tract infections (B).
Figure 2
Figure 2
Cycle threshold values of RSV A (A) and RSV B (B) according to upper and lower respiratory tract infections. CT: cycle threshold. Two-sided p-value was calculated by Mann–Whitney test.
Figure 3
Figure 3
Distribution of bronchiolitis and pneumonia according to RSV mono-infection and RSV viral co-infection. Two-sided p-value was calculated by Fisher exact test.

References

    1. Shi T., McLean K., Campbell H., Nair H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta-analysis. J. Glob. Health. 2015;5:010408. doi: 10.7189/jogh.05.010408. - DOI - PMC - PubMed
    1. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., Walsh E.E. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 2005;352:1749–1759. doi: 10.1056/NEJMoa043951. - DOI - PubMed
    1. Afonso C.L., Amarasinghe G.K., Bányai K., Bào Y., Basler C.F., Bavari S., Bejerman N., Blasdell K.R., Briand F.-X., Briese T., et al. Taxonomy of the Order Mononegavirales: Update 2016. Arch. Virol. 2016;161:2351–2360. doi: 10.1007/s00705-016-2880-1. - DOI - PMC - PubMed
    1. Mazur N.I., Caballero M.T., Nunes M.C. Severe respiratory syncytial virus infection in children: Burden, management, and emerging therapies. Lancet. 2024;404:1143–1156. doi: 10.1016/S0140-6736(24)01716-1. - DOI - PubMed
    1. Díez-Domingo J., Pérez-Yarza E.G., Melero J.A., Sánchez-Luna M., Aguilar M.D., Blasco A.J., Alfaro N., Lázaro P. Social, economic, and health impact of the respiratory syncytial virus: A systematic search. BMC Infect. Dis. 2014;14:544. doi: 10.1186/s12879-014-0544-x. - DOI - PMC - PubMed

LinkOut - more resources